Biological therapy is based on the use of active substances participating in physiological processes of the body. These can be well-known hormones, enzymes, vitamins and minerals. Less known are monoclonal antibodies, cytokines (e.g. interferons), and peptides.
These are organic molecules consisting of amino acids. If the polymer chain of such a molecule has about 10-20 amino acids, it is called an oligopeptide. 20 to 80 amino acid residues upgrades it to the category of polypeptides. More than 80 amino acids are already a protein.
On this page, we will not describe the role of proteins in the body since this is not relevant to regulatory oligo- and polypeptides. Low molecular weight peptides act inside the cell. Their main task is to activate genes responsible for the synthesis of enzymes, antioxidants, cytokines, and other important protein substances. As a result, the cell properly performs its function, acquires capacity for neutralization of free radicals and self-renewal.
It should be noted that important regulatory molecules – growth factors – also have a peptide structure. The entire complex of such molecules contained in the cell forms a so-called peptide pool. Scientists assume that the number of oligo- and polypeptides in a human cell progressively decreases with age. There is a hypothesis that a change in the composition of a cell’s peptide pool leads to its dysfunction, aging, and death. The use of peptide complexes in practical medicine demonstrates their extremely high efficiency in a fairly wide range of pathological processes.
The available scientific data create the prospects for using such products for prevention of aging and even for life extension. It is very important to note that oligo- and polypeptides are absolutely safe for the body. They do not cause allergies, overdose, any toxicity, or other undesirable effects.
Polypeptides are a new class of drug substances that opens up fantastic possibilities.